NSC |
Compound |
Enrichment |
Correlation |
NSC 733906 |
Null |
0.0147237897640499 |
-0.1163775 |
NSC 734562 |
6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride |
0.0147237897640499 |
0.13341559 |
NSC 736164 |
pyrazoline derivative |
0.0147237897640499 |
0.17186065 |
NSC 757949 |
(1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one |
0.0147237897640499 |
0.080516479 |
NSC 679001 |
2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- |
0.0164116791870034 |
0.070053889 |
NSC 682763 |
Null |
0.0164116791870034 |
0.087778629 |
NSC 690270 |
ANTINEOPLASTIC-690270 |
0.0164116791870034 |
0.050105492 |
NSC 695941 |
6H-Imidazo[4,5,1-de]acridin-6-one, 5-[3-[[3-[[5-nitro-1,3-dioxo- 2H-benz[de]isoquinolin- 2-yl]propyl](methyl)amino]propyl]amino]-, dimethanesulfonate |
0.0164116791870034 |
0.12742113 |
NSC 698058 |
Null |
0.0164116791870034 |
0.1111769 |
NSC 703092 |
Null |
0.0164116791870034 |
0.21095133 |